Here's why the NIB (ASX:NHF) share price is pushing higher today

Here's what's happening with the NIB share price today…

| More on:
An older woman clasps her hands with joy, smiling at the news on her computer as she sits at her kitchen bench..

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The NIB Holdings Limited (ASX: NHF) share price is pushing higher on Thursday morning.

In early trade, the private health insurer's shares are up over 1% to $7.02.

Why is the NIB share price pushing higher?

The catalyst for the rise in the NIB share price this morning has been the release of an update on its premium increases for next year.

According to the release, the company has received approval from the Federal Minister for Health to increase health insurance premiums by an average of 2.66%. This is the company's lowest premium change in two decades.

However, just because the premium increase has been approved, doesn't necessarily mean the company will actually increase them immediately on 1 April.

NIB's Managing Director, Mark Fitzgibbon, revealed that the company is considering deferring premium increases in recognition of the ongoing impact of COVID-19 on its members.

He said: "It's possible the increase could be deferred for likely three months depending upon developments, especially in relation to our claims experience and risk equalisation commitment. We'll provide details on what this looks like for our members in the new year."

Nobody likes premium increases but…

And while Mr Fitzgibbon acknowledged that consumers never welcome premium increases, he stressed that they are necessary to keep pace with the rising cost of healthcare treatment.

Mr Fitzgibbon commented: "We've worked hard to keep our price changes to a record low while still allowing us to fund medical treatment for our members when and where they need it. We're also investing more in our members' future health by leveraging data science and technology to deliver more personalised healthcare through unique products, digital health services and health management programs."

The Managing Director also highlighted that the company's average premiums are still lower than average. Following the 2022 premium increase, NIB's annual average premium per single equivalent unit is estimated to be $2,484. This compares to the industry average of $2,657.

Incidentally, this morning Medibank Private Ltd (ASX: MPL) one-upped NIB by announcing that it will defer its premium increases for five months from 1 April. After which, its premiums will increase by an average of 3.1%, which is its lowest increase in 21 years.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »